Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.
Takeda is getting into vaccines with the launch of a dedicated global division that will make use of Nycomed A/S’s business infrastructure in Europe and emerging markets.
Company news: FDA, Ranbaxy, Daiichi Sankyo and ImpactRx
October 6, 2011
5:42 pm
The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.
UK PR pitch could portend US acquisitions for AstraZeneca
AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.
For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.
Teva is partnering with Procter & Gamble in an OTC drug marketing joint venture that will boast annual sales of more than $1 billion — and which could ultimately be worth four times that, the companies say.
Staffers have been sent home and security has been bolstered at pharma offices located in Egypt’s capital city, amid protests in Tahrir Square that have turned violent in recent days.
Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.
Stronger growth for global pharma in 2011, says IMS